Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801928 · ClinicalTrials.gov registry record
Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 118
- Enrollment target
NCT03801928 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 118 participants.
The verdict
NCT03801928 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 118 participants
- Enrollment target
Study Summary
This is a prospective, observational, multicenter study conducted in adult patients with ulcerative colitis (UC) or Crohn's disease (CD). The study plans to recruit 300 subjects in the United States and Canada in which the participating physician has decided to treat with INFLECTRA. The study will evaluate treatment patterns, adherence, disease activity, remission status, relapse status, treatment satisfaction, and healthcare resource utilization. Patient outcomes will be assessed at four time points (quarterly) for approximately 52 weeks after the decision to initiate treatment with INFLECTRA.
Interventions
- DRUG Inflectra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2018-02-23 |
| Est. Completion | 2020-02-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03801928
The ClinicalTrials.gov registry entry for NCT03801928 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Inflectra is the first listed.
NCT03801928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03801928 about?
NCT03801928 is a clinical study titled "Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease". This is a prospective, observational, multicenter study conducted in adult patients with ulcerative colitis (UC) or Crohn's disease (CD). The study plans to recruit 300 subjects in the United States and Canada in which the participating physician has decided to treat with INFLECTRA. The study will e...
What is the current status of trial NCT03801928?
This trial is currently completed. The enrollment target is 118 participants. The study started on 2018-02-23. Estimated completion is 2020-02-07.
What interventions are being tested in trial NCT03801928?
The interventions under investigation include: Inflectra (DRUG).
Who is sponsoring clinical trial NCT03801928?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.